Quality of medical therapy in heart failure patients undergoing elective revascularisation: A protective effect of disease modifying therapy at discharge

The STICH(-ES) trial showed that coronary artery bypass grafting was superior to medical therapy alone in treating ischemic heart failure. However, dosages of disease modifying drugs were not reported. We included 128 (84% male, mean age 66 ± 11 years) consecutive patients with ischemic heart failur...

Descripción completa

Detalles Bibliográficos
Autores principales: Wurm, Raphael, Huelsmann, Martin, Hienert, Marius, Seidl, Veronika, Wiedemann, Dominik, Laufer, Guenther, Kocher, Alfred, Adlbrecht, Christopher, Andreas, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668379/
https://www.ncbi.nlm.nih.gov/pubmed/29097746
http://dx.doi.org/10.1038/s41598-017-15004-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668379/
https://www.ncbi.nlm.nih.gov/pubmed/29097746
http://dx.doi.org/10.1038/s41598-017-15004-5

Ejemplares similares